Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  NSE India Stock Exchange  >  Tata Consultancy Services    TCS   INE467B01029

TATA CONSULTANCY SERVICES

(TCS)
  Report
Delayed Quote. Delayed NSE India Stock Exchange - 01/22 06:43:35 am
3303.1 INR   +0.89%
01/20TATA CONSULTANCY SERVICES : Three UK Partners with TCS to Accelerate 5G Network Rollout
AQ
01/20Sensex, Nifty end higher on IT, Reliance boost
RE
01/20Indian shares end higher on IT, Reliance boost
RE
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Tata Consultancy Services : Named a Leader and Star Performer in Life Sciences Operations by Everest Group

02/14/2020 | 08:07am EST

Tata Consultancy Services' Significant Scale in the LS Operations Services Market, its Decision Fabric that Drives Automation and Customer Relationships, Cited as Key Strengths.

Tata Consultancy Services (TCS) (BSE: 532540, NSE: TCS), a leading global IT services, consulting and business solutions organization, has been named a Leader and Star Performer in the Everest Group PEAK Matrix for Life Sciences (LS) Operations.

In an assessment of 24 global life sciences service providers, TCS was positioned highest for Vision and Capability. Cited as a strength is TCS' significant scale in the LS operations services market, with solutions like its cloud-based TCS ADD platforms witnessing increased traction in the market, particularly the TCS Connected Clinical TrialsTM platform, which enables patient engagement and clinical supply process visibility. The report highlights that TCS is deploying automation for multiple customers in pharmacovigilance, data management, and the medical affairs segments, which is augmented by its in-house technology engine - the TCS Decision Fabric.

TCS was positioned as a Star Performer for its addition of new customers in the clinical trials and regulatory affairs value chain segments, and investments in building solutions and its talent pool to expand into newer processes such as commercial operations and supply chain.

'Life sciences enterprises are leveraging emerging technologies and next-gen platforms to overcome the challenges that come with rising costs, declining revenues, data explosion, continued M&A pursuits, and increasingly complex regulations, as well as to drive digitization in R&D and focus on specialty drugs,' said Debashis Ghosh, Business Group Head, Life Sciences and Healthcare, TCS. 'This leadership position is a validation of our vision and strategy, global scale, portfolio of domain-focused platform solutions, and the resultant market impact.'

TCS collaborates with leading life sciences companies to enable their digital transformation journey by leveraging its Business 4.0TM framework and Machine First Delivery Model (MFDMTM). TCS offers a full set of business operations and transformation services and solutions including advisory services, predictive and prescriptive analytics, clinical operations, regulatory services, laboratory platforms, AI / ML solutions, pharmacovigilance, genomics research, blockchain, and medical articles and medico marketing. Early investments in re-skilling the workforce, building agile workplaces, and developing intellectual property have helped TCS gain significant scale and depth in digital technologies.

The company's extensive portfolio of intellectual property - including the award winning TCS ADD platform suite, Real World Evidence platform, Decision Fabric engine, TCS Connected Clinical TrialsTM platform and Translational Research Platform - help customers achieve better speed to market and superior business outcomes.

'The life sciences industry is under tremendous pressure to streamline processes, comply with regulatory norms, launch newer drugs at a faster pace, and deliver real value for patients. Under the weight of such issues, the core capability of a pharma company - innovation - can often take a back seat,' says Manu Aggarwal, Vice President, Everest Group. 'TCS' investments in creating an integrated platform - the Advanced Drug Development (TCS ADD) platform - along with focus on building deep domain expertise and expansion into newer services such as commercialization is bringing the focus back on drug innovation.'

'Our focus on innovation, technology-driven solutions and platforms that digitize the life sciences value chain, contextual knowledge, as well as significant investments in innovation labs and upskilling of digital talent, position us as a preferred partner to drive our customers' growth and transformation agendas,' added Debashis Ghosh.

About Tata Consultancy Services Ltd. (TCS)

Tata Consultancy Services is an IT services, consulting and business solutions organization that has been partnering with many of the world's largest businesses in their transformation journeys for the last 50 years. TCS offers a consulting-led, cognitive powered, integrated portfolio of business, technology and engineering services and solutions. This is delivered through its unique Location Independent Agile delivery model, recognized as a benchmark of excellence in software development.

A part of the Tata group, India's largest multinational business group, TCS has over 446,000 of the world's best-trained consultants in 46 countries. The company generated consolidated revenues of US $20.9 billion in the fiscal year ended March 31, 2019, and is listed on the BSE (formerly Bombay Stock Exchange) and the NSE (National Stock Exchange) in India. TCS' proactive stance on climate change and award-winning work with communities across the world have earned it a place in leading sustainability indices such as the Dow Jones Sustainability Index (DJSI), MSCI Global Sustainability Index and the FTSE4Good Emerging Index. For more information, visit us at www.tcs.com.

TCS Media Contacts

Asia Pacific

Email: charlene.lee@tcs.com

Phone: +65 9138 4370

Australia and New Zealand

Email: Kelly.ryan@tcs.com

Phone: +61 422 989 682

Benelux

Email: Joost.galema@tcs.com

Phone: +31 615 903387

Canada

Email: tia.thomas@tcs.com

Phone: +1 647 790 7602

Central Europe

Email: anke.maibach@tcs.com

Phone: +49 172 6615789

Europe

Email: mattias.afgeijerstam@tcs.com

Phone: +46723989188

India

Email: arushie.sinha@tcs.com

Phone: +91 22 6778 9960

Japan

Email: douglas.foote@tcs.com

Phone: +81 80 2115 0989

Latin America

Email: martin.karich@tcs.com

Phone: +569 6170 9013

Nordics

Email: roland.bagen@tcs.com

Phone: +46703178024

UK

Email: peter.devery@tcs.com

Phone: +44 20 3155 2421

USA

Email: b.trounson@tcs.com

Phone: +1 646 313 4594

(C) 2020 Electronic News Publishing, source ENP Newswire

All news about TATA CONSULTANCY SERVICES
01/20TATA CONSULTANCY SERVICES : Three UK Partners with TCS to Accelerate 5G Network ..
AQ
01/20Sensex, Nifty end higher on IT, Reliance boost
RE
01/20Indian shares end higher on IT, Reliance boost
RE
01/20Indian shares edge up along with Asian peers after Yellen boost
RE
01/18TATA CONSULTANCY SERVICES : Lands Contract With UK Telecom Operator for 5G Netwo..
MT
01/14TATA CONSULTANCY SERVICES : Ex-dividend day for interim dividend
FA
01/13Infosys raises revenue forecast as demand rises
RE
01/12Indian shares hit record high as banks, Airtel gain
RE
01/12TATA CONSULTANCY SERVICES : TCS to Buy GE's Stake in Saudi Arabian JV
MT
01/12TATA CONSULTANCY SERVICES : TCS Named a Leader in the IDC MarketScape
AQ
More news
Financials
Sales 2021 1 644 B 22 526 M 22 526 M
Net income 2021 329 B 4 512 M 4 512 M
Net cash 2021 264 B 3 623 M 3 623 M
P/E ratio 2021 37,5x
Yield 2021 1,43%
Capitalization 12 218 B 167 B 167 B
EV / Sales 2021 7,27x
EV / Sales 2022 6,36x
Nbr of Employees 469 261
Free-Float 26,9%
Chart TATA CONSULTANCY SERVICES
Duration : Period :
Tata Consultancy Services Technical Analysis Chart | TCS | INE467B01029 | MarketScreener
Technical analysis trends TATA CONSULTANCY SERVICES
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 40
Average target price 3 259,03 INR
Last Close Price 3 303,10 INR
Spread / Highest target 26,4%
Spread / Average Target -1,33%
Spread / Lowest Target -43,1%
EPS Revisions
Managers and Directors
NameTitle
Rajesh Gopinathan CEO, MD & Non-Independent Executive Director
Natarajan Chandrasekaran Non-Executive Chairman
N. Ganapathy Subramaniam COO & Non-Independent Executive Director
V. Ramakrishnan Chief Financial Officer
K. Ananth Krishnan Chief Technology Officer
Sector and Competitors
1st jan.Capitalization (M$)
TATA CONSULTANCY SERVICES15.38%167 410
ACCENTURE PLC-2.47%161 584
INTERNATIONAL BUSINESS MACHINES CORPORATION-5.78%105 688
INFOSYS LIMITED6.77%77 956
AUTOMATIC DATA PROCESSING, INC.-8.61%69 459
VMWARE, INC.-4.11%56 460